Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obese, Type 2 Diabetes”

182 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 182 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06918405
What this trial is testing

Efficacy and Safety of Tirzepatide for Weight Management

Who this might be right for
Obesity and Obesity-related Medical Conditions
Chittagong Medical College 440
Large-scale testing (Phase 3)Active Not RecruitingNCT05929066
What this trial is testing

Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Who this might be right for
ObesityOverweightOsteoarthritis, Knee+1 more
Eli Lilly and Company 2,300
Large-scale testing (Phase 3)Not Yet RecruitingNCT07321886
What this trial is testing

Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company 1,980
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of Mediterranean Diet Combined With Intermittent Fasting on Liver Fibrosis Compared to Naltrexone/Bupropion in People With Cardiometabolic Risk Factors (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableLooking for participantsNCT05908812
What this trial is testing

Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity

Who this might be right for
SarcopeniaObesityDiabetes Mellitus, Type 2
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 120
Early research (Phase 1)Looking for participantsNCT07399678
What this trial is testing

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Who this might be right for
Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc. 180
Early research (Phase 1)Looking for participantsNCT07137585
What this trial is testing

Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity

Who this might be right for
Type 2 Diabetes MellitusObesityOverweight
Hoffmann-La Roche 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05929079
What this trial is testing

Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

Who this might be right for
Type 2 DiabetesObesityOverweight+1 more
Eli Lilly and Company 1,000
Post-approval studies (Phase 4)Looking for participantsNCT05872269
What this trial is testing

Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Who this might be right for
NAFLDObesityType 2 Diabetes+2 more
Zydus Lifesciences Limited 1,500
Not applicableStudy completedNCT01559896
What this trial is testing

Egg Protein Hydrolysate and Vascular Function

Who this might be right for
Arterial StiffnessDietary ModificationImpaired Glucose Tolerance+1 more
Maastricht University Medical Center 40
Large-scale testing (Phase 3)Active Not RecruitingNCT07104500
What this trial is testing

VK2735 for Weight Management Phase 3

Who this might be right for
Weight Loss
Viking Therapeutics, Inc. 4,500
Not applicableStudy completedNCT05322122
What this trial is testing

Creation of Side-to-Side Compression Anastomosis Using the Magnetic Anastomosis System

Who this might be right for
Obesity
GT Metabolic Solutions, Inc. 49
Large-scale testing (Phase 3)Looking for participantsNCT07220759
What this trial is testing

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

Who this might be right for
OverweightObesityType 2 Diabetes
Novo Nordisk A/S 330
Large-scale testing (Phase 3)Looking for participantsNCT07282600
What this trial is testing

Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Who this might be right for
OverweightObesity
Eli Lilly and Company 1,035
Testing effectiveness (Phase 2)Looking for participantsNCT06897475
What this trial is testing

LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT06926842
What this trial is testing

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Who this might be right for
OverweightType 2 DiabetesObesity
Zealand Pharma 221
Post-approval studies (Phase 4)UnknownNCT05005741
What this trial is testing

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Who this might be right for
Diabetes Mellitus, Type 2Overweight or Obesity
Second Xiangya Hospital of Central South University 120
Early research (Phase 1)Study completedNCT06567041
What this trial is testing

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Novo Nordisk A/S 82
Not applicableStudy completedNCT06613724
What this trial is testing

Magnetic Duodeno-Ileal Chile Study

Who this might be right for
ObesityType 2 Diabetes Mellitus (T2DM)
GT Metabolic Solutions, Inc. 10
Load More Results